they got $628,000 after end of quarter as an R&D grant so should tide them over for a while but it is clear their cashflow position is questionable and unsustainable so i expect an announcement re tiwi going ahead along with a capital raising or convertible bond or spp to fund it. this is a 3-10 year stock which could reward the patient in spades - but will take funding to derisk.
- Forums
- ASX - By Stock
- anyone follow this? lt multi-bag?
they got $628,000 after end of quarter as an R&D grant so should...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MPA (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.002(2.86%) |
Mkt cap ! $29.24M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 7.2¢ | $720 | 10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 320932 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 320932 | 0.070 |
2 | 92000 | 0.065 |
1 | 150000 | 0.064 |
1 | 10000 | 0.030 |
1 | 300000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 50000 | 1 |
0.075 | 216197 | 1 |
0.078 | 41000 | 1 |
0.090 | 23000 | 2 |
0.095 | 100000 | 1 |
Last trade - 12.12pm 12/11/2024 (20 minute delay) ? |
Featured News
MPA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online